NC318
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NC318, covering 2024-03-08 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]